<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37373021</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>08</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>No Evidence for Myocarditis or Other Organ Affection by Induction of an Immune Response against Critical SARS-CoV-2 Protein Epitopes in a Mouse Model Susceptible for Autoimmunity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9873</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24129873</ELocationID><Abstract><AbstractText>After <i>Severe acute respiratory syndrome coronavirus 2</i> (SARS-CoV-2) developed into a global pandemic, not only the infection itself but also several immune-mediated side effects led to additional consequences. Immune reactions such as epitope spreading and cross-reactivity may also play a role in the development of long-COVID, although the exact pathomechanisms have not yet been elucidated. Infection with SARS-CoV-2 can not only cause direct damage to the lungs but can also lead to secondary indirect organ damage (e.g., myocardial involvement), which is often associated with high mortality. To investigate whether an immune reaction against the viral peptides can lead to organ affection, a mouse strain known to be susceptible to the development of autoimmune diseases, such as experimental autoimmune myocarditis (EAM), was used. First, the mice were immunized with single or pooled peptide sequences of the virus's spike (SP), membrane (MP), nucleocapsid (NP), and envelope protein (EP), then the heart and other organs such as the liver, kidney, lung, intestine, and muscle were examined for signs of inflammation or other damage. Our results showed no significant inflammation or signs of pathology in any of these organs as a result of the immunization with these different viral protein sequences. In summary, immunization with different SARS-CoV-2 spike-, membrane-, nucleocapsid-, and envelope-protein peptides does not significantly affect the heart or other organ systems adversely, even when using a highly susceptible mouse strain for experimental autoimmune diseases. This suggests that inducing an immune reaction against these peptides of the SARS-CoV-2 virus alone is not sufficient to cause inflammation and/or dysfunction of the myocardium or other studied organs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ignatz</LastName><ForeName>Rebecca Maria</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0001-5604-6639</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zirkenbach</LastName><ForeName>Vanessa Antje</ForeName><Initials>VA</Initials><Identifier Source="ORCID">0000-0001-9405-8286</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaya</LastName><ForeName>Mansur</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stroikova</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;ttl</LastName><ForeName>Renate</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frey</LastName><ForeName>Norbert</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaya</LastName><ForeName>Ziya</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-3745-0836</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, University of Heidelberg, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">autoimmune</Keyword><Keyword MajorTopicYN="N">cardiovascular damage</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37373021</ArticleId><ArticleId IdType="pmc">PMC10298153</ArticleId><ArticleId IdType="doi">10.3390/ijms24129873</ArticleId><ArticleId IdType="pii">ijms24129873</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., Hu Y., Tao Z.W., Tian J.H., Pei Y.Y., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265&#x2013;269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann. Saudi Med. 2016;36:78&#x2013;80. doi: 10.5144/0256-4947.2016.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.5144/0256-4947.2016.78</ArticleId><ArticleId IdType="pmc">PMC6074274</ArticleId><ArticleId IdType="pubmed">26922692</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G., Pellegrini C., Maurelli M., Belliato M., Sciutti F., Bottazzi A., Sepe P.A., Resasco T., Camporotondo R., Bruno R., et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur. J. Heart Fail. 2020;22:911&#x2013;915. doi: 10.1002/ejhf.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsamanesh N., Karami-Zarandi M., Banach M., Penson P.E., Sahebkar A. Effects of statins on myocarditis: A review of underlying molecular mechanisms. Prog. Cardiovasc. Dis. 2021;67:53&#x2013;64. doi: 10.1016/j.pcad.2021.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2021.02.008</ArticleId><ArticleId IdType="pubmed">33621589</ArticleId></ArticleIdList></Reference><Reference><Citation>Wibowo A., Pranata R., Akbar M.R., Purnomowati A., Martha J.W. Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression. Int. J. Infect. Dis. 2021;105:312&#x2013;318. doi: 10.1016/j.ijid.2021.02.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.02.113</ArticleId><ArticleId IdType="pmc">PMC7923942</ArticleId><ArticleId IdType="pubmed">33667694</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewek J., Jatczak-Pawlik I., Maciejewski M., Jankowski P., Banach M. COVID-19 and cardiovascular complications&#x2014;Preliminary results of the LATE-COVID study. Arch. Med. Sci. 2021;17:818&#x2013;822. doi: 10.5114/aoms/134211.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms/134211</ArticleId><ArticleId IdType="pmc">PMC8130484</ArticleId><ArticleId IdType="pubmed">34025853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J., Ma S., Wang Y., Cai Z., Hu J., Wei N., Wu J., Du H., Chen T., Li R., et al. Factors Associated with Mental Health Outcomes among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Netw. Open. 2020;3:e203976. doi: 10.1001/jamanetworkopen.2020.3976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.3976</ArticleId><ArticleId IdType="pmc">PMC7090843</ArticleId><ArticleId IdType="pubmed">32202646</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons S., Fodil S., Azoulay E., Zafrani L. The vascular endothelium: The cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit. Care. 2020;24:353. doi: 10.1186/s13054-020-03062-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03062-7</ArticleId><ArticleId IdType="pmc">PMC7296907</ArticleId><ArticleId IdType="pubmed">32546188</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U., Zinkernagel A.S., Shambat S.M., Zeng X., Cathomas G., Ruschitzka F., Schuepbach R.A., Moch H., Varga Z. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. eBioMedicine. 2021;63:103182. doi: 10.1016/j.ebiom.2020.103182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103182</ArticleId><ArticleId IdType="pmc">PMC7808909</ArticleId><ArticleId IdType="pubmed">33422990</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlen M., Fagerberg L., Hallstrom B.M., Lindskog C., Oksvold P., Mardinoglu A., Sivertsson A., Kampf C., Sjostedt E., Asplund A., et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419. doi: 10.1126/science.1260419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1260419</ArticleId><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F., Mear L., Edvinsson A., Micke P., Uhlen M., Lindskog C. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 2020;16:e9610. doi: 10.15252/msb.20209610.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Li X., Chen M., Feng Y., Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc. Res. 2020;116:1097&#x2013;1100. doi: 10.1093/cvr/cvaa078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa078</ArticleId><ArticleId IdType="pmc">PMC7184507</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450&#x2013;454. doi: 10.1038/nature02145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker M.W., Guo H.F., Li X., Linkugel A.D., Vander Kooi C.W. Function of members of the neuropilin family as essential pleiotropic cell surface receptors. Biochemistry. 2012;51:9437&#x2013;9446. doi: 10.1021/bi3012143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi3012143</ArticleId><ArticleId IdType="pmc">PMC3510667</ArticleId><ArticleId IdType="pubmed">23116416</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H.F., Vander Kooi C.W. Neuropilin Functions as an Essential Cell Surface Receptor. J. Biol. Chem. 2015;290:29120&#x2013;29126. doi: 10.1074/jbc.R115.687327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R115.687327</ArticleId><ArticleId IdType="pmc">PMC4705917</ArticleId><ArticleId IdType="pubmed">26451046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayi B.S., Leibowitz J.A., Woods A.T., Ammon K.A., Liu A.E., Raja A. The role of Neuropilin-1 in COVID-19. PLoS Pathog. 2021;17:e1009153. doi: 10.1371/journal.ppat.1009153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009153</ArticleId><ArticleId IdType="pmc">PMC7781380</ArticleId><ArticleId IdType="pubmed">33395426</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly J.L., Simonetti B., Klein K., Chen K.E., Williamson M.K., Anton-Plagaro C., Shoemark D.K., Simon-Gracia L., Bauer M., Hollandi R., et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370:861&#x2013;865. doi: 10.1126/science.abd3072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3072</ArticleId><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856&#x2013;860. doi: 10.1126/science.abd2985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohail S., Rana H., Awan D.S., Sohail F., Rishi A.I., Karamat M., Khan S., Adil K. Proteolytic Transformation and Stimulation of SARS-CoV-2 Spike Protein with Human ACE-2 Receptor. Austin J. Microbiol. 2021;6:1035.</Citation></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., Steig B., Gaini S., Gaini S., Strom M., Weihe P. Long COVID in the Faroe Islands: A Longitudinal Study among Nonhospitalized Patients. Clin. Infect. Dis. 2021;73:e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn A., Krist L., Lieb W., Montellano F.A., Kohls M., Haas K., Gelbrich G., Bolay-Gehrig S.J., Morbach C., Reese J.P., et al. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: Design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP) Infection. 2021;49:1277&#x2013;1287. doi: 10.1007/s15010-021-01707-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01707-5</ArticleId><ArticleId IdType="pmc">PMC8508400</ArticleId><ArticleId IdType="pubmed">34642875</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., Saevik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Cristanziano V.D., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., Harris A.M. Post&#x2013;COVID Conditions among Adult COVID-19 Survivors Aged 18&#x2013;64 and &#x2265;65 Years&#x2014;United States, March 2020&#x2013;November 2021. MMWR Morb. Mortal. Wkly. Rep. 2022;71:713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Post-COVID Conditions: Information for Healthcare Providers.  [(accessed on 4 June 2023)];2021  Available online:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Billig Rose E., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health among Outpatients with COVID-19 in a Multistate Health Care Systems Network&#x2014;United States, March&#x2013;June 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Gonzalez A., Araujo-Ameijeiras A., Fernandez-Villar A., Crespo M., Poveda E., Cohort C.-o.t.G.S.H.R.I. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci. Rep. 2022;12:3369. doi: 10.1038/s41598-022-07414-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Flemming A. First glimpses into the mechanisms of Long COVID. Nat. Rev. Immunol. 2022;22:146. doi: 10.1038/s41577-022-00691-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00691-7</ArticleId><ArticleId IdType="pmc">PMC8853331</ArticleId><ArticleId IdType="pubmed">35169258</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Fernandez A., Wamil M., Telford A., Carapella V., Borlotti A., Monteiro D., Thomaides-Brears H., Kelly M., Dennis A., Banerjee R., et al. Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection. Open Heart. 2023;10:e002241. doi: 10.1136/openhrt-2022-002241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2022-002241</ArticleId><ArticleId IdType="pmc">PMC9950586</ArticleId><ArticleId IdType="pubmed">36822818</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: A prospective, community-based study. BMJ Open. 2021;11:e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Eichert N., Mouchti S., Pansini M., Roca-Fernandez A., Thomaides-Brears H., et al. Multi-organ impairment and long COVID: A 1-year prospective, longitudinal cohort study. J. R. Soc. Med. 2023;116:97&#x2013;112. doi: 10.1177/01410768231154703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231154703</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Xu E., Al-Aly Z. Kidney Outcomes in Long COVID. J. Am. Soc. Nephrol. 2021;32:2851&#x2013;2862. doi: 10.1681/ASN.2021060734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021060734</ArticleId><ArticleId IdType="pmc">PMC8806085</ArticleId><ArticleId IdType="pubmed">34470828</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e820. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F., Chen F., Ou Z., Fan Q., Tan X., Wang Y., Pan Y., Ke B., Li L., Guan Y., et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell. Mol. Immunol. 2020;17:1119&#x2013;1125. doi: 10.1038/s41423-020-00550-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00550-2</ArticleId><ArticleId IdType="pmc">PMC7546387</ArticleId><ArticleId IdType="pubmed">33037400</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Levy R., Henriquez S., Bodemer C., Szwebel T.A., Casanova J.L. Interferon-beta Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2. J. Clin. Immunol. 2021;41:931&#x2013;933. doi: 10.1007/s10875-021-01023-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01023-5</ArticleId><ArticleId IdType="pmc">PMC7990897</ArticleId><ArticleId IdType="pubmed">33763778</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur J.M., Forrest J.C., Boehme K.W., Kennedy J.L., Owens S., Herzog C., Liu J., Harville T.O. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS ONE. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated with Post-acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M., Freitag H., Rudolf G., Seifert M., Doehner W., Scherbakov N., Hanitsch L., Wittke K., Bauer S., Konietschke F., et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibn Hadj Amor H., Jdidi J., Torjmen S., Kraiem S., Hammami R., Bahloul A., Kallel N., Moussa N., Touil I., et al. Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study. Front. Cardiovasc. Med. 2021;8:745758. doi: 10.3389/fcvm.2021.745758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., Furst J., Schulze-Rothe S., Wallukat A., Honicke A.S., Muller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J. Transl. Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy W.J., Longo D.L. A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination. N. Engl. J. Med. 2022;386:394&#x2013;396. doi: 10.1056/NEJMcibr2113694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2113694</ArticleId><ArticleId IdType="pubmed">34818473</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornaby C., Gibbons L., Mayhew V., Sloan C.S., Welling A., Poole B.D. B cell epitope spreading: Mechanisms and contribution to autoimmune diseases. Immunol. Lett. 2015;163:56&#x2013;68. doi: 10.1016/j.imlet.2014.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2014.11.001</ArticleId><ArticleId IdType="pubmed">25445494</ArticleId></ArticleIdList></Reference><Reference><Citation>Harkiolaki M., Holmes S.L., Svendsen P., Gregersen J.W., Jensen L.T., McMahon R., Friese M.A., van Boxel G., Etzensperger R., Tzartos J.S., et al. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity. 2009;30:348&#x2013;357. doi: 10.1016/j.immuni.2009.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.01.009</ArticleId><ArticleId IdType="pubmed">19303388</ArticleId></ArticleIdList></Reference><Reference><Citation>Korte W., Buljan M., Rosslein M., Wick P., Golubov V., Jentsch J., Reut M., Peier K., Nohynek B., Fischer A., et al. SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on. J. Infect. 2021;82:e11&#x2013;e14. doi: 10.1016/j.jinf.2020.08.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.032</ArticleId><ArticleId IdType="pmc">PMC7445467</ArticleId><ArticleId IdType="pubmed">32853597</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura Y., Sawahata M., Nakamura Y., Koike R., Katsube O., Hagiwara K., Niho S., Masuda N., Tanaka T., Sugiyama K. Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months. Vaccines. 2021;9:1500. doi: 10.3390/vaccines9121500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9121500</ArticleId><ArticleId IdType="pmc">PMC8708461</ArticleId><ArticleId IdType="pubmed">34960246</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A., Sidney J., Zhang Y., Scheuermann R.H., Peters B., Sette A. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2. Cell Host Microbe. 2020;27:671&#x2013;680.e672. doi: 10.1016/j.chom.2020.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.03.002</ArticleId><ArticleId IdType="pmc">PMC7142693</ArticleId><ArticleId IdType="pubmed">32183941</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A., Li F. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221&#x2013;224. doi: 10.1038/s41586-020-2179-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2179-y</ArticleId><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181:281&#x2013;292.e286. doi: 10.1016/j.cell.2020.02.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Nomura N., Muramoto Y., Ekimoto T., Uemura T., Liu K., Yui M., Kono N., Aoki J., Ikeguchi M., et al. Structure of SARS-CoV-2 membrane protein essential for virus assembly. Nat. Commun. 2022;13:4399. doi: 10.1038/s41467-022-32019-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32019-3</ArticleId><ArticleId IdType="pmc">PMC9355944</ArticleId><ArticleId IdType="pubmed">35931673</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.K., Hou M.H., Chang C.F., Hsiao C.D., Huang T.H. The SARS coronavirus nucleocapsid protein&#x2014;Forms and functions. Antivir. Res. 2014;103:39&#x2013;50. doi: 10.1016/j.antiviral.2013.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2013.12.009</ArticleId><ArticleId IdType="pmc">PMC7113676</ArticleId><ArticleId IdType="pubmed">24418573</ArticleId></ArticleIdList></Reference><Reference><Citation>Goser S., Andrassy M., Buss S.J., Leuschner F., Volz C.H., Ottl R., Zittrich S., Blaudeck N., Hardt S.E., Pfitzer G., et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation. 2006;114:1693&#x2013;1702. doi: 10.1161/CIRCULATIONAHA.106.635664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.635664</ArticleId><ArticleId IdType="pubmed">17015788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya Z., Goser S., Buss S.J., Leuschner F., Ottl R., Li J., Volkers M., Zittrich S., Pfitzer G., Rose N.R., et al. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation. 2008;118:2063&#x2013;2072. doi: 10.1161/CIRCULATIONAHA.108.788711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.788711</ArticleId><ArticleId IdType="pmc">PMC2774217</ArticleId><ArticleId IdType="pubmed">18955666</ArticleId></ArticleIdList></Reference><Reference><Citation>Bockstahler M., Fischer A., Goetzke C.C., Neumaier H.L., Sauter M., Kespohl M., Muller A.M., Meckes C., Salbach C., Schenk M., et al. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation. Circulation. 2020;141:1885&#x2013;1902. doi: 10.1161/CIRCULATIONAHA.119.043171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043171</ArticleId><ArticleId IdType="pubmed">32160764</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A., Bockstahler M., Muller A.M., Stroikova V., Leib C., Pfitzer G., Katus H.A., Kaya Z. FN14 Signaling Plays a Pathogenic Role in a Mouse Model of Experimental Autoimmune Myocarditis. J. Card. Fail. 2019;25:674&#x2013;685. doi: 10.1016/j.cardfail.2019.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2019.06.003</ArticleId><ArticleId IdType="pubmed">31212034</ArticleId></ArticleIdList></Reference><Reference><Citation>Katus H.A., Looser S., Hallermayer K., Remppis A., Scheffold T., Borgya A., Essig U., Geuss U. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin. Chem. 1992;38:386&#x2013;393. doi: 10.1093/clinchem/38.3.386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/38.3.386</ArticleId><ArticleId IdType="pubmed">1547556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleuel H., Deschl U., Bertsch T., Bolz G., Rebel W. Diagnostic efficiency of troponin T measurements in rats with experimental myocardial cell damage. Exp. Toxicol. Pathol. 1995;47:121&#x2013;127. doi: 10.1016/S0940-2993(11)80297-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0940-2993(11)80297-6</ArticleId><ArticleId IdType="pubmed">7580098</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaias J., Mineau M., Cray C., Yoon D., Altman N.H. Reference values for serum proteins of common laboratory rodent strains. J. Am. Assoc. Lab. Anim. Sci. 2009;48:387&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2715929</ArticleId><ArticleId IdType="pubmed">19653947</ArticleId></ArticleIdList></Reference><Reference><Citation>Roopenian D.C., Low B.E., Christianson G.J., Proetzel G., Sproule T.J., Wiles M.V. Albumin-deficient mouse models for studying metabolism of human albumin and pharmacokinetics of albumin-based drugs. mAbs. 2015;7:344&#x2013;351. doi: 10.1080/19420862.2015.1008345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19420862.2015.1008345</ArticleId><ArticleId IdType="pmc">PMC4623309</ArticleId><ArticleId IdType="pubmed">25654695</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues W.F., Miguel C.B., Napimoga M.H., Oliveira C.J., Lazo-Chica J.E. Establishing standards for studying renal function in mice through measurements of body size-adjusted creatinine and urea levels. BioMed Res. Int. 2014;2014:872827. doi: 10.1155/2014/872827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/872827</ArticleId><ArticleId IdType="pmc">PMC4163481</ArticleId><ArticleId IdType="pubmed">25243193</ArticleId></ArticleIdList></Reference><Reference><Citation>Aigner B., Rathkolb B., Herbach N., Kemter E., Schessl C., Klaften M., Klempt M., de Angelis M.H., Wanke R., Wolf E. Screening for increased plasma urea levels in a large-scale ENU mouse mutagenesis project reveals kidney disease models. Am. J. Physiol. Renal Physiol. 2007;292:F1560&#x2013;F1567. doi: 10.1152/ajprenal.00213.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00213.2006</ArticleId><ArticleId IdType="pubmed">17264314</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristiansson A., Orbom A., Ahlstedt J., Karlsson H., Zedan W., Gram M., Akerstrom B., Strand S.E., Altai M., Strand J., et al. (177)Lu-PSMA-617 Therapy in Mice, with or without the Antioxidant alpha(1)-Microglobulin (A1M), Including Kidney Damage Assessment Using (99m)Tc-MAG3 Imaging. Biomolecules. 2021;11:263. doi: 10.3390/biom11020263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11020263</ArticleId><ArticleId IdType="pmc">PMC7916794</ArticleId><ArticleId IdType="pubmed">33579037</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallimann T., Wyss M., Brdiczka D., Nicolay K., Eppenberger H.M. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The &#x2018;phosphocreatine circuit&#x2019; for cellular energy homeostasis. Pt 1Biochem. J. 1992;281:21&#x2013;40. doi: 10.1042/bj2810021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2810021</ArticleId><ArticleId IdType="pmc">PMC1130636</ArticleId><ArticleId IdType="pubmed">1731757</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlattner U., Tokarska-Schlattner M., Wallimann T. Mitochondrial creatine kinase in human health and disease. Biochim. Biophys. Acta. 2006;1762:164&#x2013;180. doi: 10.1016/j.bbadis.2005.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2005.09.004</ArticleId><ArticleId IdType="pubmed">16236486</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Yao L., Wei T., Tian F., Jin D.Y., Chen L., Wang M. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020;323:1406&#x2013;1407. doi: 10.1001/jama.2020.2565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2565</ArticleId><ArticleId IdType="pmc">PMC7042844</ArticleId><ArticleId IdType="pubmed">32083643</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Pneumonia of Unknown Cause&#x2014;China. 2020.  [(accessed on 4 June 2023)].  Available online:  https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/</Citation></Reference><Reference><Citation>Gavriatopoulou M., Korompoki E., Fotiou D., Ntanasis-Stathopoulos I., Psaltopoulou T., Kastritis E., Terpos E., Dimopoulos M.A. Organ-specific manifestations of COVID-19 infection. Clin. Exp. Med. 2020;20:493&#x2013;506. doi: 10.1007/s10238-020-00648-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-020-00648-x</ArticleId><ArticleId IdType="pmc">PMC7383117</ArticleId><ArticleId IdType="pubmed">32720223</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.P., Li H.M., Tao W.Q., Yang X.J., Wang M., Yang W.J., Liu J.P. Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients. Aging. 2020;12:10059&#x2013;10069. doi: 10.18632/aging.103255.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103255</ArticleId><ArticleId IdType="pmc">PMC7346014</ArticleId><ArticleId IdType="pubmed">32484453</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., Filippini N., Griffanti L., Alfaro-Almagro F., Okell T., Sheerin F., Xie C., Mahmod M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. eClinicalMedicine. 2021;31:100683. doi: 10.1016/j.eclinm.2020.100683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Mei X.W., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., Watkinson P., Khunti K., Harnden A., Coupland C.A.C., et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 2022;28:410&#x2013;422. doi: 10.1038/s41591-021-01630-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01630-0</ArticleId><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>Irabien-Ortiz A., Carreras-Mora J., Sionis A., Pamies J., Montiel J., Tauron M. Fulminant myocarditis due to COVID-19. Rev. Esp. Cardiol. (Engl. Ed.) 2020;73:503&#x2013;504. doi: 10.1016/j.recesp.2020.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.recesp.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7158782</ArticleId><ArticleId IdType="pubmed">32345547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T., Hu J., et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 2020;11:1620. doi: 10.1038/s41467-020-15562-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15562-9</ArticleId><ArticleId IdType="pmc">PMC7100515</ArticleId><ArticleId IdType="pubmed">32221306</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuschner F., Katus H.A., Kaya Z. Autoimmune myocarditis: Past, present and future. J. Autoimmun. 2009;33:282&#x2013;289. doi: 10.1016/j.jaut.2009.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2009.07.009</ArticleId><ArticleId IdType="pubmed">19679447</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan M.Z., Islam S., Matsumoto K., Kawai T. SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs. Sci. Rep. 2021;11:16814. doi: 10.1038/s41598-021-96110-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-96110-3</ArticleId><ArticleId IdType="pmc">PMC8376961</ArticleId><ArticleId IdType="pubmed">34413339</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanali G., di Masi A., Trezza V., Marino M., Fasano M., Ascenzi P. Human serum albumin: From bench to bedside. Mol. Asp. Med. 2012;33:209&#x2013;290. doi: 10.1016/j.mam.2011.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2011.12.002</ArticleId><ArticleId IdType="pubmed">22230555</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez C.M., McClain C.J., Marsano L.S. Albumin therapy in clinical practice. Nutr. Clin. Pract. 2005;20:314&#x2013;320. doi: 10.1177/0115426505020003314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0115426505020003314</ArticleId><ArticleId IdType="pubmed">16207669</ArticleId></ArticleIdList></Reference><Reference><Citation>Pundir C.S., Jakhar S., Narwal V. Determination of urea with special emphasis on biosensors: A review. Biosens. Bioelectron. 2019;123:36&#x2013;50. doi: 10.1016/j.bios.2018.09.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2018.09.067</ArticleId><ArticleId IdType="pubmed">30308420</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw S.M., Gibney R.T. Conventional markers of kidney function. Crit. Care Med. 2008;36:S152&#x2013;S158. doi: 10.1097/CCM.0b013e318168c613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318168c613</ArticleId><ArticleId IdType="pubmed">18382187</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum N., Dichoso C.C., Carlton C.E. Blood urea nitrogen and serum creatinine: Physiology and interpretations. Urology. 1975;5:583&#x2013;588. doi: 10.1016/0090-4295(75)90105-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0090-4295(75)90105-3</ArticleId><ArticleId IdType="pubmed">1093306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornsson T.D. Use of serum creatinine concentrations to determine renal function. Clin. Pharmacokinet. 1979;4:200&#x2013;222. doi: 10.2165/00003088-197904030-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003088-197904030-00003</ArticleId><ArticleId IdType="pubmed">383355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozer J., Ratner M., Shaw M., Bailey W., Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology. 2008;245:194&#x2013;205. doi: 10.1016/j.tox.2007.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2007.11.021</ArticleId><ArticleId IdType="pubmed">18291570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kathirvel E., Morgan K., French S.W., Morgan T.R. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. Nutr. Res. 2013;33:932&#x2013;941. doi: 10.1016/j.nutres.2013.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2013.08.001</ArticleId><ArticleId IdType="pubmed">24176233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J., Xu Y., Zhang M., Li Y. Geraniol ameliorates acute liver failure induced by lipopolysaccharide/D-galactosamine via regulating macrophage polarization and NLRP3 inflammasome activation by PPAR-gamma methylation Geraniol alleviates acute liver failure. Biochem. Pharmacol. 2023;10:115467. doi: 10.1016/j.bcp.2023.115467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2023.115467</ArticleId><ArticleId IdType="pubmed">36849063</ArticleId></ArticleIdList></Reference><Reference><Citation>Burhop K., Gordon D., Estep T. Review of hemoglobin-induced myocardial lesions. Artif. Cells Blood Substit. Immobil. Biotechnol. 2004;32:353&#x2013;374. doi: 10.1081/BIO-200027429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/BIO-200027429</ArticleId><ArticleId IdType="pubmed">15508274</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathwani R.A., Pais S., Reynolds T.B., Kaplowitz N. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology. 2005;41:380&#x2013;382. doi: 10.1002/hep.20548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.20548</ArticleId><ArticleId IdType="pubmed">15660433</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawalha K., Abozenah M., Kadado A.J., Battisha A., Al-Akchar M., Salerno C., Hernandez-Montfort J., Islam A.M. Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome. Cardiovasc. Revasc Med. 2021;23:107&#x2013;113. doi: 10.1016/j.carrev.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carrev.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7434380</ArticleId><ArticleId IdType="pubmed">32847728</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Katus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin. Chem. 2010;56:254&#x2013;261. doi: 10.1373/clinchem.2009.132654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2009.132654</ArticleId><ArticleId IdType="pubmed">19959623</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R.Y., Zhu X.F., Yang Y., Ye P. High-sensitive cardiac troponin T. J. Geriatr. Cardiol. 2013;10:102&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3627711</ArticleId><ArticleId IdType="pubmed">23610580</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrassy M., Volz H.C., Maack B., Schuessler A., Gitsioudis G., Hofmann N., Laohachewin D., Wienbrandt A.R., Kaya Z., Bierhaus A., et al. HMGB1 is associated with atherosclerotic plaque composition and burden in patients with stable coronary artery disease. PLoS ONE. 2012;7:e52081. doi: 10.1371/journal.pone.0052081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052081</ArticleId><ArticleId IdType="pmc">PMC3524090</ArticleId><ArticleId IdType="pubmed">23284878</ArticleId></ArticleIdList></Reference><Reference><Citation>Saenger A.K., Beyrau R., Braun S., Cooray R., Dolci A., Freidank H., Giannitsis E., Gustafson S., Handy B., Katus H., et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin. Chim. Acta. 2011;412:748&#x2013;754. doi: 10.1016/j.cca.2010.12.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2010.12.034</ArticleId><ArticleId IdType="pubmed">21219893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Afanasyeva M., Hill S.L., Kaya Z., Rose N.R. Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice. J. Am. Coll. Cardiol. 2000;36:1992&#x2013;1999. doi: 10.1016/S0735-1097(00)00939-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(00)00939-6</ArticleId><ArticleId IdType="pubmed">11092676</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya Z., Afanasyeva M., Wang Y., Dohmen K.M., Schlichting J., Tretter T., Fairweather D., Holers V.M., Rose N.R. Contribution of the innate immune system to autoimmune myocarditis: A role for complement. Nat. Immunol. 2001;2:739&#x2013;745. doi: 10.1038/90686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/90686</ArticleId><ArticleId IdType="pubmed">11477411</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>